Impact of Prior Therapies on the Safety and Efficacy of Once Weekly Selinexor, Bortezomib, and Dexamethasone Compared with Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Results from the Boston Study

Details

Request a copyRequest a copy
Serval ID
serval:BIB_BCDE55D77838
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
Production externe
Title
Impact of Prior Therapies on the Safety and Efficacy of Once Weekly Selinexor, Bortezomib, and Dexamethasone Compared with Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Results from the Boston Study
Title of the conference
Blood
Author(s)
Mateos Maria, Jagannath Sundar, Delimpasi Sosana, Simonova Maryana, Spicka Ivan, Pour Ludek, Kryachok Irina, Gavriatopoulou Maria, Dimopoulos Meletios A, Pylypenko Halyna, Auner Holger W, Leleu Xavier, Doronin Vadim A, Usenko Ganna, Benjamin Reuben, Dolai Tuphan Kanti, Sinha Dinesh Kumar, Venner Christopher P., Garg Mamta, Stevens Don A., Quach Hang, Moreau Philippe, Levy Moshe Y., Badros Ashraf Z., Anderson Larry D., Bahlis Nizar J., Facon Thierry, Cavo Michele, Chai Yi, Arazy Melina, Shah Jatin, Shacham Sharon, Kauffman Michael G, Richardson Paul G., Grosicki Sebastian
Publisher
American Society of Hematology
ISSN
0006-4971
1528-0020
Publication state
Published
Issued date
05/11/2020
Volume
136
Number
Supplement 1
Pages
50-52
Language
english
DOI
10.1182/blood-2020-137574
Web of science
000607547203056
Open Access
Yes
Create date
02/12/2024 17:49
Last modification date
04/12/2024 8:07
Usage data